FDA Approved First Medication for Obstructive Sleep Apnea
On Dec. 20, 2024, the U.S. Food and Drug Administration (FDA) approved Eli Lilly’s Zepbound (tirzepatide) for the…
Urgent action needed as global diabetes cases increase four-fold over past decades
On Nov. 13, 2024, the NCD Risk Factor Collaboration (NCD-RisC) with support from the World Health Organization (WHO)…
PET Scan based on lizard saliva detected rare tumor
On Oct. 18, 2024, a research team led by Radboud university medical center reported that a new PET…
Stem cells reverse woman’s diabetes — a world first
On Sept. 26, 2024, a team of scientists in Peking University in Beijing, China announced that a 25-year-old…
Study Revealed How COVID-19 Infection Can Cause or Worsen Diabetes
On Sept. 13, 2024, researchers from Weill Cornell Medicine have used a cutting-edge model system to uncover the…
Biotechnology | Diagnostics | Disease | Oncology | Therapeutics | WHO
Nearly 1.8 billion adults at risk of disease from not doing enough physical activity
On Jun. 26. 2024, the World Health Organization reported that new data show that nearly one third (31%)…
University of Illinois and Universidade de Sao Paulo develop first transgenic cow to produce human insulin in her milk
On Mar. 13, 2024, an unassuming brown bovine from the south of Brazil has made history as the…
FDA cleared first Over-the-Counter continuous glucose monitor
On Mar. 5, 2024, the U.S. Food and Drug Administration cleared for marketing the first over-the-counter (OTC) continuous…
Milestones in Diabetes
Milestones in Diabetes illustrates major milestones from the first administration of the hormone insulin in 1921 to a…
Biotechnology | Diagnostics | Genomics | NIH | Therapeutics
Large-scale genetic analysis showed microRNAs in human pancreas associated with diabetes
On Feb. 9, 2023, the National Institutes of Health (NIH) announced that a new large-scale genetic analysis found…
Biotechnology | Disease | FDA | Therapeutics
FDA approved first drug that can delay onset of Type 1 Diabetes
On Nov. 17, 2022, the U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) injection to delay the…
NIH study compares low-fat, plant-based diet to low-carb, animal-based diet
On Jan. 21, 2021, the National Institutes of Health announced results of a small but highly controlled study…
USC scientists launched global effort to find the next diabetes drug
On Mar. 23, 2018, University of Southern California (USC) researchers launched a massive scientific effort to construct a…
Bristol-Myers Squibb announced closure of Seattle’s ZymoGenetics operation
On Dec. 13, 2016, Bristol-Myers Squibb announced that it would not renew its lease at the Lake Union…
Landmark study generated Mature human insulin-producing pancreatic beta cells from stem cells in vitro
On Oct. 9, 2014, a landmark study led by Douglas Melton from Harvard University successfully generated functional, mature human…
William Hagopian was appointed Scientific Director at the Pacific Northwest Diabetes Research Institute
On Nov. 11, 2009, the Pacific Northwest Diabetes Research Institute announced the appointment of William Hagopian, M.D., Ph.D.,…
William Hagopian launched The Environmental Determinants of Diabetes in the Young study
In 2004, William Hagopian, M.D., Ph.D., launched The Environmental Determinants of Diabetes in the Young (TEDDY) study at…
Pacific Northwest Research Institute led consortium that conducted first human islet transplantation in Puget Sound region
On Jul. 30, 2002, Dr. R. Paul Robertson, President and Scientific Director at the Pacific Northwest Research Foundation…
ZymoGenetics dedicated Seattle’s historic Lake Union Steam Plant
On Sept. 8, 1994, ZymoGenetics dedicated Seattle’s historic Lake Union Steam Plant. The renovated 113,000 s.f. plant doubled…
Lake Union Steam Plant and Hydro House were designated City of Seattle landmarks
On Aug. 1, 1994, the ZymoGenetics Lake Union Steam Plant and Hydro House were designated City of Seattle…
ZymoGenetics began a $25 million year-long renovation of the The Seattle City Light Steam Plant building
On May 13, 1993, ZymoGenetics began a $25 million year-long renovation of the The Seattle City Light Steam…
Molecular biologist Lydia Villa-Komaroff authored a paper demonstrating that bacteria could produce insulin
In 1978, molecular biologist Lydia Villa-Komaroff authored a paper demonstrating that bacteria could produce insulin. Lydia’s research helped make…
James Collip produced the first insulin for humans
In Jan. 1922, James Bertram Collip produced the first insulin for humans. The Nobel Prize in Physiology or…
Hoeschst blocked from completing a Frankfurt plant for the production of genetically engineered human insulin
In 1989, the Administrative Supreme Court of the state of Hesse, West Germany, blocks the multinational chemical company…
Eli Lilly introduced Humulin insulin identical to that produced by the human body
In 1987, Eli Lilly and Company introduced Humulin insulin identical to that produced by the human body. Humulin…
The first recombinant vaccine for humans, a vaccine for hepatitis B, was approved
In May 1986, the vaccine Recombivax HB, which protects against hepatitis B infection, was approved for marketing in…
Biotechnology | Disease | FDA | Therapeutics
The first biotech drug, human insulin produced in genetically modified bacteria, was approved by FDA
On Oct. 28, 1982, the U.S. Food and Drug Administration (FDA) approved Humulin, Eli Lily’s recombinant insulin made…
ZymoGenetics was incorporated
On Jun. 22, 1981, ZymoGenetics was founded by University of Washington professors Earl Davie and Benjamin Hall, and…
First insulin pump for diabetes was developed
In 1979, Dr. Robert Sherwin and Dr. William Tamborlane from Yale University announced they had developed an insulin…
Genentech successfully cloned the gene encoding human insulin in Escherichia coli bacteria
On Sept. 6, 1978, Genentech, the most successful of the new biotech start-up companies, announced that scientists at…